These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8444821)

  • 21. Mood stabilizer loading versus titration in acute mania: audit of clinical practice.
    Wheeler A; Robinson G; Fraser A
    Aust N Z J Psychiatry; 2008 Nov; 42(11):955-62. PubMed ID: 18941960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium carbonate as a potential pharmacological vehicle: intravenous kinetics of single-dose administration in healthy subjects.
    Waring WS; Webb DJ; Maxwell SR
    Eur J Clin Pharmacol; 2002 Sep; 58(6):431-4. PubMed ID: 12242603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a new lithium dosage-prediction technique.
    Dugas JE; Feeney AM
    Clin Pharm; 1983; 2(3):249-52. PubMed ID: 6411414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single daily dosage of lithium carbonate.
    Hammond CM
    Ann Pharmacother; 1994 Apr; 28(4):472-4. PubMed ID: 8038471
    [No Abstract]   [Full Text] [Related]  

  • 26. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequate testing of lithium dose prediction.
    Swartz CM
    J Clin Psychiatry; 1994 May; 55(5):215-6. PubMed ID: 8071273
    [No Abstract]   [Full Text] [Related]  

  • 28. A computerised sampling strategy for therapeutic drug monitoring of lithium provides precise estimates and significantly reduces dose-finding time.
    Hoegberg LC; Jürgens G; Zederkof VW; Holgersson B; Andersson JE; Dalhoff KP; Larsen EB; Angelo HR
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):259-63. PubMed ID: 21933347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary excretion of albumin and transferrin in lithium maintenance treatment: daily versus alternate-day lithium dosing schedule.
    Jensen HV; Holm J; Davidsen K; Toftegaard L; Aggernaes H; Bjørum N
    Psychopharmacology (Berl); 1995 Dec; 122(3):317-20. PubMed ID: 8748403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simpler and more accurate equation to predict daily lithium dose.
    Terao T; Okuno K; Okuno T; Nakano H; Shinkai T; Ohmori O; Yoshimura R; Suzuki T; Abe K
    J Clin Psychopharmacol; 1999 Aug; 19(4):336-40. PubMed ID: 10440461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of two lithium maintenance dose schedules.
    Perry PJ; Alexander B; Prince RA; Dunner FJ
    J Clin Psychopharmacol; 1984 Oct; 4(5):242-6. PubMed ID: 6490961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium neurotoxicity at low therapeutic doses Hypotheses for causes and mechanism of action following a retrospective analysis of published case reports.
    Emilien G; Maloteaux JM
    Acta Neurol Belg; 1996 Dec; 96(4):281-93. PubMed ID: 9008777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium treatment: a comparison of once- and twice-daily dosing.
    Abraham G; Delva N; Waldron J; Lawson JS; Owen J
    Acta Psychiatr Scand; 1992 Jan; 85(1):65-9. PubMed ID: 1546552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delirium syndrome as a side-effect of lithium in normal lithium levels].
    Niethammer R; Keller A; Weisbrod M
    Psychiatr Prax; 2000 Sep; 27(6):296-7. PubMed ID: 11050737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.